AnaptysBio is Biotechnology in United States that focus on collaborative research business. Founded in 2005. They cover business area such as AnaptysBio Inc, clinical-stage biotechnology company, antibody product candidate, unmet medical need, inflammation, immuno-oncology, emerge biological target, its proprietary, antibody discovery technology platform, antibody generation, its product candidate, checkpoint receptor agonist, revenue.
2005
( 19 years old in 2024 )
Collaborative Research
-
10421 Pacific Center Court
Suite 200
San Diego, CA 92121
United States
Private
AnaptysBio Incclinical-stage biotechnology companyantibody product candidateunmet medical needinflammationimmuno-oncologyemerge biological targetits proprietary, antibody discovery technology platformantibody generationits product candidatecheckpoint receptor agonistrevenue
* We use standard office opening hours in near AnaptysBio's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
AnaptysBio is Biotechnology business from United States that founded in 2005 (19 years old in 2024), AnaptysBio business is focusing on Collaborative Research.
AnaptysBio headquarter office and corporate office address is located in 10421 Pacific Center Court Suite 200 San Diego, CA 92121 United States.
AnaptysBio was founded in United States.
In 2024, AnaptysBio is currently focus on collaborative research sector.
Above is snippet of Google Trends for "collaborative research" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with AnaptysBio, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.
